Department of Urology, Seoul National University Bundang Hospital, Seongnam, Kyunggi-do 463-707, Korea.
We investigated the prognostic significance of percentage of tumour involvement (PTI) according to the clinicopathological features of prostate cancer among patients who underwent radical prostatectomy (RP). A retrospective study of 534 patients who underwent RP between September 2003 and March 2008 without any neoadjuvant or adjuvant therapy was performed. The associations of PTI with various clinicopathological features and biochemical recurrence-free survival were examined via uni- and multivariate analyses. The predictive accuracy of the multivariate model was assessed with a receiver operating characteristics-derived area under the curve. PTI was demonstrated to be significantly associated with preoperative prostate-specific antigen (PSA) level (P=0.001), pathological Gleason score (P< 0.001), extraprostatic tumour extension (P< 0.001), seminal vesicle invasion (P< 0.001) and positive surgical margin (P< 0.001) in univariate analyses. When patients were stratified into disease risk groups, PTI was an independent predictor of biochemical recurrence-free survival in multivariate analysis only among the low-risk group (P=0.033) but not the intermediate- (P=0.287) or the high-risk groups (P=0.828). The addition of the PTI did not significantly increase the accuracy of the multivariate model devised for the prediction of biochemical recurrence-free survival among both total patients (P=0.459) and the low-risk group (P=0.268), respectively. In conclusion, although PTI appeared to be a more significant prognostic factor among patients with low-risk disease than among those with higher risk diseases, overall, the PTI may not provide additional prognostic information beyond what can already be obtained via established prognostic factors.
Written by:
Jin Oh J, Cheol Lee S, Wook Jeong C, Yong Yoon C, Jin Jeong S, Kyu Hong S, Byun SS, Kwan Rho Y, Choe G, Eun Lee S. Are you the author?
Reference: Asian J Androl. 2011 Sep 26. Epub ahead of print.
doi: 10.1038/aja.2011.111
PubMed Abstract
PMID: 21946230
UroToday.com Prostate Cancer Section
